| 1 |
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Leena Gandhi et al. · New England Journal of Medicine
Open access |
16 Apr 2018 |
6,764 |
| 2 |
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Stephen G. O’Brien et al. · New England Journal of Medicine
Open access |
12 Mar 2003 |
3,593 |
| 3 |
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Brian J. Druker et al. · New England Journal of Medicine
Open access |
6 Dec 2006 |
3,508 |
| 4 |
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch, Giorgio V. Scagliotti, James L. Mulshine et al. · The Lancet
Open access |
2 Sep 2016 |
3,404 |
| 5 |
International evidence-based recommendations for point-of-care lung ultrasound
Giovanni Volpicelli et al. · Intensive Care Medicine
Open access |
5 Mar 2012 |
2,919 |
| 6 |
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Silvia Novello, Fabrice Barlési, Raffaele Califano et al. · Annals of Oncology
Open access |
Sep 2016 |
2,650 |
| 7 |
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Luciano Gattinoni, Davide Chiumello, Pietro Caironi et al. · Intensive Care Medicine
Open access |
14 Apr 2020 |
1,951 |
| 8 |
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Brunangelo Falini et al. · New England Journal of Medicine
Open access |
19 Jan 2005 |
1,923 |
| 9 |
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Giuseppe Saglio, Dong‐Wook Kim, Surapol Issaragrisil et al. · New England Journal of Medicine
Open access |
5 Jun 2010 |
1,691 |
| 10 |
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
J Gäbert, Emmanuel Jean Beillard, Vincent H. J. van der Velden et al. · Leukemia
|
9 Oct 2003 |
1,540 |
| 11 |
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley Harris Beecham et al. · Nature Genetics
Open access193 authors |
29 Sep 2013 |
1,466 |
| 12 |
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer
Shirish M. Gadgeel et al. · Journal of Clinical Oncology
Open access |
9 Mar 2020 |
1,181 |
| 13 |
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
JJM van Dongen, EA Macintyre, J Gäbert et al. · Leukemia
|
Dec 1999 |
1,174 |
| 14 |
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Heather A. Wakelee, Moïshe Liberman, Terufumi Kato et al. · New England Journal of Medicine
Open access |
3 Jun 2023 |
1,142 |
| 15 |
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Martin Reck, Rolf Kaiser, Anders Mellemgaard et al. · The Lancet Oncology
Open access |
8 Jan 2014 |
962 |
| 16 |
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
in cooperation with the Neuromyelitis Optica Study Group (NEMOS) et al. · Journal of Neuroinflammation
Open access |
28 Oct 2016 |
901 |
| 17 |
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program
Emmanuel Jean Beillard, Niels Pallisgaard, Vincent H. J. van der Velden et al. · Leukemia
|
9 Oct 2003 |
887 |
| 18 |
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Antonella Roetto, George V. Papanikolaou, Marianna Politou et al. · Nature Genetics
|
9 Dec 2002 |
866 |
| 19 |
Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
Roberto Marchioli et al. · New England Journal of Medicine
Open access |
8 Dec 2012 |
845 |
| 20 |
Oxidative Stress and Cell Signalling
Giuseppe Poli, Gabriella Leonarduzzi, Fiorella Biasi et al. · Current Medicinal Chemistry
|
May 2004 |
722 |
| 21 |
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery
Giancarlo Agnelli, Giorgio Bolis, Lorenzo Capussotti et al. · Annals of Surgery
Open access |
21 Dec 2005 |
695 |
| 22 |
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
Giorgio V. Scagliotti, Nasser H. Hanna, Frank V. Fossella et al. · The Oncologist
Open access |
16 Feb 2009 |
694 |
| 23 |
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
Giampaolo Bucaneve, Alessandra Micozzi, Francesco Menichetti et al. · New England Journal of Medicine
Open access |
7 Sep 2005 |
650 |
| 24 |
Pathogenesis of liver fibrosis: role of oxidative stress
Giuseppe Poli · Molecular Aspects of Medicine
|
Jun 2000 |
635 |
| 25 |
Poorly Differentiated Thyroid Carcinoma: The Turin Proposal for the Use of Uniform Diagnostic Criteria and an Algorithmic Diagnostic Approach
Marco Volante, Paola Collini, Yuri E. Nikiforov et al. · The American Journal of Surgical Pathology
|
23 Jul 2007 |
624 |
| 26 |
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
Kazuhiko Nakagawa et al. · The Lancet Oncology
Open access131 authors |
4 Oct 2019 |
619 |
| 27 |
Bedside lung ultrasound in the assessment of alveolar-interstitial syndrome
Giovanni Volpicelli, Alessandro Mussa, Giorgio Garofalo et al. · The American Journal of Emergency Medicine
|
19 Sep 2006 |
615 |
| 28 |
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
Adrianus Johannes De Langen et al. · The Lancet
Open access |
7 Feb 2023 |
609 |
| 29 |
Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
Giorgio V. Scagliotti · JNCI Journal of the National Cancer Institute
Open access |
30 Sep 2003 |
603 |
| 30 |
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen et al. · Nature Genetics
Open access282 authors |
Dec 2021 |
579 |
| 31 |
Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study
Franco Luigi Cavalot, Alessio Petrelli, Monica Traversa et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
7 Feb 2006 |
577 |
| 32 |
Myelin-oligodendrocyte glycoprotein antibody-associated disease
Romain Marignier et al. · The Lancet Neurology
Open access |
18 Aug 2021 |
540 |
| 33 |
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
Talmadge E. King, Carlo Albera, Williamson Z. Bradford et al. · The Lancet
Open access |
30 Jun 2009 |
537 |
| 34 |
AME Position Statement on adrenal incidentaloma
Massimo Terzolo, Antonio Stigliano, Iacopo Chiodini et al. · European Journal of Endocrinology
Open access |
7 Apr 2011 |
518 |
| 35 |
Breaking the neuronal sphere: regulation of the actin cytoskeleton in neuritogenesis
Jorge Santos Da Silva, Carlos G. Dotti · Nature reviews. Neuroscience
Review |
Sep 2002 |
479 |
| 36 |
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti et al. · Annals of Neurology
Open access |
22 Jan 2021 |
464 |
| 37 |
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Martin Faßnacht, Guillaume Assié, Eric Baudin et al. · Annals of Oncology
Open access |
27 Aug 2020 |
435 |
| 38 |
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
in cooperation with the Neuromyelitis Optica Study Group (NEMOS) et al. · Journal of Neuroinflammation
Open access |
27 Oct 2016 |
434 |
| 39 |
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
Giovanni Fucà et al. · British Journal of Cancer
Open access |
18 May 2020 |
397 |
| 40 |
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
Elias Joseph Jabbour, Hagop M. Kantarjian, Giuseppe Saglio et al. · Blood
Open access |
5 Dec 2013 |
396 |
| 41 |
How I do it: Lung ultrasound
Luna Gargani, Giovanni Volpicelli · Cardiovascular Ultrasound
Open access |
3 Jul 2014 |
394 |
| 42 |
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
Sara Bringhen et al. · Blood
Open access |
31 Aug 2010 |
383 |
| 43 |
T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β
Luca Durelli, Laura Monteiro de Castro Conti, Marinella Clerico et al. · Annals of Neurology
|
20 Mar 2009 |
377 |
| 44 |
Glucocorticoid-induced osteoporosis: an update
Gherardo Mazziotti, Alberto Angeli, John Paul Bilezikian et al. · Trends in Endocrinology and Metabolism
Review |
May 2006 |
368 |
| 45 |
Endoscopic Combined Intrarenal Surgery in Galdakao-Modified Supine Valdivia Position: A New Standard for Percutaneous Nephrolithotomy?
Cesare Marco Scoffone, Cecilia Maria Cracco, Marco Cossu et al. · European Urology
|
13 Aug 2008 |
368 |
| 46 |
Recommendations to Standardize Preanalytical Confounding Factors in Alzheimer’s and Parkinson’s Disease Cerebrospinal Fluid Biomarkers: An Update
Marta del Campo, Brit Mollenhauer, Antonio Bertolotto et al. · Biomarkers in Medicine
|
Aug 2012 |
361 |
| 47 |
Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)
Manu L. N. G. Malbrain, Thomas M Langer, Djillali Annane et al. · Annals of Intensive Care
Open access |
2020 |
335 |
| 48 |
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Alfredo Berruti, Eric Baudin, Hans A. J. Gelderblom et al. · Annals of Oncology
Open access |
20 Sep 2012 |
332 |
| 49 |
Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial
Luigi Dogliotti, Giacomo Cartenì, Salvatore Siena et al. · European Urology
|
2 Jan 2007 |
332 |
| 50 |
Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome?
Massimo Terzolo, Anna Rosa Pia, Anna Alı̀ et al. · The Journal of Clinical Endocrinology & Metabolism
|
Mar 2002 |
327 |